Who are Another Available A1PI's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): AAT.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/another-available-a1pi.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Another Available A1PI — Competitive Intelligence Brief

Another Available A1PI (Another Available A1PI) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Protease inhibitor replacement therapy. Area: Pulmonology / Respiratory.

marketed Protease inhibitor replacement therapy Alpha-1 protease inhibitor (A1PI) Pulmonology / Respiratory Biologic Live · refreshed every 30 min

Target snapshot

Another Available A1PI (Another Available A1PI) — Takeda. This drug replaces deficient alpha-1 protease inhibitor (A1PI) protein to prevent progressive lung damage in patients with alpha-1 antitrypsin deficiency.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Another Available A1PI TARGET	Another Available A1PI	Takeda	marketed	Protease inhibitor replacement therapy	Alpha-1 protease inhibitor (A1PI)
AAT	AAT	Rabin Medical Center	marketed	Protease inhibitor replacement therapy	Alpha-1 antitrypsin (serum protein replacement)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Protease inhibitor replacement therapy class)

Rabin Medical Center · 1 drug in this class
Takeda · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Another Available A1PI — Competitive Intelligence Brief. https://druglandscape.com/ci/another-available-a1pi. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab